3. How does GTC produce its transgenic goats?
GTC has produced transgenic goats using two different methods – pronuclear microinjection and now exclusively nuclear transfer. Nuclear transfer, performed in a laboratory dish, entails taking a cell carrying the “new” DNA, which codes for the desired therapeutic protein, and fusing it to a donor goat’s egg (that has had its genetic material removed). These eggs are then implanted into a surrogate female goat which she will carry to term. All offspring born using this process are transgenic.
6. Are GTC’s methods for producing and/or maintaining transgenic goats monitored by credible outside experts?
Yes, all of GTC’s procedures involving the goats are manditorilly monitored by the USDA (United States Department of Agriculture) and periodically by AAALAC International (Association for Assessment and Accreditation of Laboratory Animal Care International). In addition to these external oversight authorities that perform inspections and/or site visits, GTC includes 2 non-company affiliated members (1 outside expert and 1 lay member) on its own internal IACUC (Institutional Animal Care and Use Committee). The IACUC reviews all of our animal protocols before implementation, performs annual re-assessments of protocols, reviews the animal care and use and veterinary care programs and performs inspections of all animal facilities and animals in residence a minimum of twice annually.